
International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
AIMAR-2025
Conferences Published ↓
ICCE (2025)
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 7 Issue 4
July-August 2025
Indexing Partners



















“Intermittent Fasting and Type 2 Diabetes: Impacts on Glycemic Control and Metabolic Health
Author(s) | Ms. Tvisa Punyatoya, Dr. Bhavana S |
---|---|
Country | India |
Abstract | Type 2 Diabetes Mellitus (T2DM) remains a growing global health challenge, driven by increasing obesity, poor dietary patterns, and sedentary lifestyles. In recent years, intermittent fasting (IF) has emerged as a promising non-pharmacological intervention for improving glycemic control and metabolic outcomes in T2DM patients. This review explores the mechanisms linking IF to enhanced insulin sensitivity, reduced oxidative stress, circadian regulation, and metabolic flexibility. Clinical trials and meta-analyses have demonstrated significant improvements in HbA1c, fasting glucose, weight loss, and insulin resistance with various IF regimens such as time restricted eating (TRE), alternate-day fasting (ADF), and the 5:2 protocol. However, the long-term safety and sustainability of IF remain under investigation, especially in populations with comorbidities or those on glucose-lowering medications. The review highlights emerging directions such as personalized fasting protocols guided by genetics, microbiome profiling, and artificial intelligence (AI)-driven tools. Challenges such as adherence, cultural barriers, healthcare provider training, and lack of standardized clinical guidelines are also addressed. Ultimately, IF shows potential as an adjunctive strategy in T2DM management, warranting further research and careful integration into clinical practice. |
Keywords | Intermittent Fasting, Type 2 Diabetes Mellitus (T2DM), Glycemic Control, Insulin Sensitivity, Time-Restricted Eating (TRE), Alternate-Day Fasting (ADF), Metabolic Health, HbA1c Reduction |
Published In | Volume 7, Issue 4, July-August 2025 |
Published On | 2025-07-03 |
DOI | https://doi.org/10.36948/ijfmr.2025.v07i04.49922 |
Short DOI | https://doi.org/g9r7pp |
Share this

E-ISSN 2582-2160

CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
